Medication adherence issues in patients treated for COPD
暂无分享,去创建一个
Ruben D. Restrepo | Donna D. Gardner | R. Wilkins | R. Restrepo | Leonard D. Wittnebel | R. Wettstein | D. Vines | H. Sorenson | M. T. Alvarez | Jennifer Sikkema-Ortiz | M. T. Álvarez | Donna D Gardner
[1] S. Bannister,et al. A Qualitative Study , 2009 .
[2] A. Park,et al. CENTER FOR DRUG EVALUATION AND RESEARCH , 2009 .
[3] B. Riley,et al. CENTER FOR DRUG EVALUATION AND RESEARCH , 2009 .
[4] C. Mullins,et al. Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] C. P. Schayck,et al. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. , 2008, Family practice.
[6] R. Dhand,et al. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[7] D. Haupt,et al. Medication persistence among patients with asthma/COPD drugs , 2008, Pharmacy World & Science.
[8] L. Ring,et al. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10‐year period , 2007, Journal of clinical pharmacy and therapeutics.
[9] T. Lasserson,et al. Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.
[10] L. Ring,et al. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication , 2007, Pharmacoepidemiology and drug safety.
[11] Bernhard Gleich,et al. Targeted delivery of magnetic aerosol droplets to the lung , 2007, Nature Nanotechnology.
[12] R. Negro,et al. Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients , 2007, International journal of chronic obstructive pulmonary disease.
[13] M. Dimatteo,et al. Health Beliefs, Disease Severity, and Patient Adherence: A Meta-Analysis , 2007, Medical care.
[14] S. Colman,et al. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. , 2007, The American journal of medicine.
[15] Yugi Oba. Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease. , 2007, Mayo Clinic proceedings.
[16] J. Bourbeau,et al. Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease , 2007, Annals of Internal Medicine.
[17] L. Ring,et al. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions , 2007, Pharmacoepidemiology and drug safety.
[18] J. van der Palen,et al. Comparison of the Diskus inhaler and the Handihaler regarding preference and ease of use. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[19] Jan B. Oostenbrink,et al. Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain , 2007, The European Journal of Health Economics.
[20] G. Alexopoulos,et al. An intervention to improve depression care in older adults with COPD , 2007, International journal of geriatric psychiatry.
[21] T. Lasserson,et al. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.
[22] T. Lasserson,et al. Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.
[23] T. Lasserson,et al. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.
[24] G. Crompton. The adult patient’s difficulties with inhalers , 2007, Lung.
[25] T. Lim,et al. Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore. , 2006, Respiratory medicine.
[26] H. Luk,et al. Teaching chronic obstructive airway disease patients using a metered-dose inhaler. , 2006, Chinese medical journal.
[27] Saunak Sen,et al. Polypharmacy and Prescribing Quality in Older People , 2006, Journal of the American Geriatrics Society.
[28] T. Lasserson,et al. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.
[29] J. Oppenheimer. Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines , 2006 .
[30] Kathleen C Insel,et al. The Negative Association of Independent Personality and Medication Adherence , 2006, Journal of aging and health.
[31] Parisa Aslani,et al. Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information , 2006, Health expectations : an international journal of public participation in health care and health policy.
[32] P Zabel,et al. [Chronic obstructive pulmonary disease (COPD)]. , 2006, Der Internist.
[33] J. George,et al. Factors associated with medication nonadherence in patients with COPD: Chest 2005;128:3198–204 , 2006 .
[34] A. Melander,et al. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. , 2005, European journal of public health.
[35] J. George,et al. Factors associated with medication nonadherence in patients with COPD. , 2005, Chest.
[36] R. Kaplan,et al. Quality of life as an outcome measure in pulmonary diseases. , 2005, Journal of cardiopulmonary rehabilitation.
[37] R. Pauwels,et al. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD , 2005, European Respiratory Journal.
[38] Emily R. Hajjar,et al. Unnecessary Drug Use in Frail Older People at Hospital Discharge , 2005, Journal of the American Geriatrics Society.
[39] J. L. Rau. The inhalation of drugs: advantages and problems. , 2005, Respiratory care.
[40] D. Nash,et al. Pharmacy utilization and the Medicare Modernization Act. , 2005, The Milbank quarterly.
[41] R. Rodríguez-Roisín. The Airway Pathophysiology of COPD: Implications for Treatment , 2005, COPD.
[42] H. Smyth. Propellant-driven metered-dose inhalers for pulmonary drug delivery , 2005, Expert opinion on drug delivery.
[43] J. L. Rau,et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. , 2005, Chest.
[44] M. Hyland,et al. A qualitative study of compliance with medication and lifestyle modification in Chronic Obstructive Pulmonary Disease (COPD). , 2004, Primary care respiratory journal : journal of the General Practice Airways Group.
[45] A. C. Moore,et al. Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handihaler , 2004, International journal of clinical practice.
[46] B. Stuart. Navigating the new Medicare drug benefit. , 2004, The American journal of geriatric pharmacotherapy.
[47] R. Kaplan,et al. Behavioral Interventions for Patients with COPD , 2004 .
[48] P. Calverley,et al. Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.
[49] S. De Geest,et al. Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[50] B. Make. Chronic obstructive pulmonary disease: developing comprehensive management. , 2003, Respiratory care.
[51] N. Anthonisen,et al. Contemporary management of chronic obstructive pulmonary disease: scientific review. , 2003, JAMA.
[52] N. Hanania,et al. The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD , 2003 .
[53] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[54] R. Sansores,et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[55] N. Hanania,et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. , 2003, Chest.
[56] P. Burkhart,et al. Adherence to long-term therapies: evidence for action. , 2003, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.
[57] J. Yates,et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[58] L. Rubenstein,et al. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. , 2002, The American journal of managed care.
[59] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.
[60] C. M. Roberts,et al. Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease. , 2002, Respiratory medicine.
[61] R. Goldstein,et al. The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease. , 2002, Canadian respiratory journal.
[62] D. Postma,et al. Chronic obstructive pulmonary disease. , 2002, Clinical evidence.
[63] V. Plaza,et al. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[64] S. Smith,et al. The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation. , 2002, Health technology assessment.
[65] B. Penninx,et al. Determinants of an incorrect inhalation technique in patients with asthma or COPD. , 2001, Scandinavian journal of primary health care.
[66] M. De Salvo,et al. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. , 2001, Chest.
[67] M. Pahor,et al. Predicting length of stay of older patients with exacerbated chronic obstructive pulmonary disease , 2001, Aging.
[68] Morris Weinberger,et al. Suboptimal Prescribing in Older Inpatients and Outpatients , 2001, Journal of the American Geriatrics Society.
[69] P. Barry,et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. , 2001, Health technology assessment.
[70] P. Cardon,et al. A qualitative study. , 2001 .
[71] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[72] M. Dimatteo,et al. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.
[73] S. Ramsey,et al. Suboptimal medical therapy in COPD: exploring the causes and consequences. , 2000, Chest.
[74] M. Biraghi,et al. Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. , 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[75] P. Bakke,et al. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? , 1999, American journal of respiratory and critical care medicine.
[76] K. Farmer,et al. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. , 1999, Clinical therapeutics.
[77] L. Sichletidis,et al. BRONCHODILATORY RESPONSES TO FORMOTEROL, IPRATROPIUM, AND THEIR COMBINATION IN PATIENTS WITH STABLE COPD , 1999, International journal of clinical practice.
[78] A. Haycox,et al. Clinical guidelines—the hidden costs , 1999, British medical journal.
[79] N. Gross,et al. Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease , 1998, Respiration.
[80] I. Mesters,et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.
[81] J. J. Klein,et al. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.
[82] J. J. Klein,et al. Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines. , 1997, Patient education and counseling.
[83] B. Strom,et al. Impact of pharmaceutical underutilization: a study of insurance drug claims data. , 1997, Journal of the American Pharmaceutical Association.
[84] G. Cochrane,et al. Psychological factors associated with use of home nebulized therapy for COPD. , 1996, The European respiratory journal.
[85] J. J. Klein,et al. Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. , 1995, Thorax.
[86] J. Nilsson,et al. Large Differences between Prescribed and Dispensed Medicines Could Indicate Undertreatment , 1995 .
[87] M. Cowles,et al. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. , 1995, American journal of respiratory and critical care medicine.
[88] N. Anthonisen,et al. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. , 1995, Chest.
[89] J. V. D. Palen,et al. Matige techniek bij het gebruik van inhalatiemedicatie door patiënten met chronische bronchitis/longemfyseem , 1994 .
[90] D. Parry,et al. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? , 1994, The European respiratory journal.
[91] K. Grathwohl,et al. Misuse of metered-dose inhalers in hospitalized patients. , 1994, Chest.
[92] J. J. Klein,et al. [Poor technique in the use of inhalation drugs by patients with chronic bronchitis/pulmonary emphysema]. , 1994, Nederlands tijdschrift voor geneeskunde.
[93] N. Pearce,et al. A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. , 1993, Current medical research and opinion.
[94] B. Niggemann. Substitution of metered-dose inhalers for hand-held nebulizers. , 1993, Chest.
[95] C. Rand,et al. Metered-dose inhaler adherence in a clinical trial. , 1992, The American review of respiratory disease.
[96] B. Zimmerman,et al. Patient compliance. Are we wasting our time and don't know it? , 1992, The American review of respiratory disease.
[97] G. Crompton,et al. Breath-actuated inhalers in chronic asthma: comparison of Diskhaler and Turbohaler for delivery of beta-agonists. , 1992, The European respiratory journal.
[98] C. van Weel,et al. Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique. , 1992, Family practice.
[99] E. Haponik,et al. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. , 1992, Chest.
[100] S. Mcphee,et al. Undermedication Among Geriatric Outpatients: Results of a Randomized Controlled Trial , 1992, Annual Review of Gerontology and Geriatrics.
[101] G. Cochrane. Therapeutic compliance in asthma; its magnitude and implications. , 1992, The European respiratory journal.
[102] W. Bailey,et al. Medication adherence patterns in chronic obstructive pulmonary disease. , 1991, Chest.
[103] S. Bartuś,et al. Noncompliance in organ transplant recipients. , 1990, Transplantation.
[104] D. Hull,et al. Noncompliance in Organ Transplant Recipients , 1989, Transplantation.
[105] B. Juknialis,et al. Inhaled Aerosol Bronchodilators , 1986 .
[106] L. Green,et al. Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.
[107] P. N. James,et al. Patterns of drug taking in patients with chronic airflow obstruction. , 1985, Postgraduate medical journal.
[108] G. Snider,et al. Distinguishing among asthma, chronic bronchitis, and emphysema. , 1985, Chest.
[109] D. Taylor,et al. Patient compliance with oral theophylline therapy. , 1984, British journal of clinical pharmacology.
[110] J. Winter. Do patients cash prescriptions? , 1982, British medical journal.
[111] P. Frith,et al. Compliance with aerosol therapy in chronic obstructive lung disease. , 1981, The New Zealand medical journal.
[112] L. Green,et al. Health promotion and maintenance for patients with chronic obstructive pulmonary disease: a review. , 1980, Journal of chronic diseases.
[113] A. Strauss. Chronic illness and the quality of life , 1975 .
[114] P Ley,et al. A method for increasing patients' recall of information presented by doctors , 1973, Psychological Medicine.
[115] Masoud Parsania,et al. THE PATIENTS , 1982, California state journal of medicine.